...

AmiKana.BioLogics

Vieraile verkkosivulla

Tietoja työnantajasta

AmiKana.BioLogics is a privately held biotech company incorporated in December 2007. It operates from laboratory space in the La Timone Faculty of Medicine in Marseille, France. Our goal is to improve the clinical management of patients failing therapy by providing tools for drug resistance analysis using the yeast cell. The implementation of AmiKana’s tools will allow optimization of personalized medicine and improve drug development. AmiKana.BioLogics holds exclusive rights, on patent protected methods, to market the tools it develops.

THE YEAST CELL AS A CELLULAR READER OF DRUG RESISTANCE PHENOMENA

Drug resistance, the result of specific mutations in drug targets and/or related target proteins, leads to lack of response to therapy. While protein sequencing, in search of resistance-conferring mutations, is an appropriate approach when the repertoire is known, functional analysis is required for unknown mutation repertoires. The drug resistance functional analyses on the market are complex and require either an appropriate laboratory for cell culture and/or a certified Level 3 containment facility. AmiKana.BioLogics develops a new variety of biological tools for implementation in microbiology laboratories, using the yeast cell as a cellular reader of drug resistance. These tools analyze drug resistances in a cellular, reproducible, user-friendly, easy-to-read, and low-cost system. AmiKana.BioLogics’ first product addresses both HIV resistance diagnostics/treatment optimization, and services to pharmaceutical companies targeting viral infectious diseases.

Clinical Partners

AmiKana.BioLogics has signed partnership agreements, for the implementation of clinical studies related to HIV and HCV diagnostic tools, with the:

  • Virology Laboratory (Laboratoire de virology), La Timone Hospital, Marseille, France, headed by Pr Didier Raoult.
  • Infectious Diseases Department (Service d’infectiologie), Nice University Hospital, France, headed by Pr. Pierre Dellamonica.
  • Fundacion HUESPED, Buenos Aires Argentina, chaired by Dr Pedro Cah, head of Infectious Diseases Unit at Hospital Juan A. Fernandez of Buenos Aires.

Työnantajan sijainti

Löydä samanlaisia työnantajia

...
KTH Royal Institute of Technology Tukholma, Ruotsi 107 avointa työpaikkaa
...
KU Leuven Leuven, Belgia 104 avointa työpaikkaa
...
University of Luxembourg Luxemburg 100 avointa työpaikkaa
...
Ghent University Gent, Belgia 71 avointa työpaikkaa
...
University of Twente Enschede, Alankomaat 62 avointa työpaikkaa
Lisää työnantajia

Kiinnostavia artikkeleita

...
5 Reasons to Pursue Your PhD at EMBL European Molecular Biology Laboratory (EMBL) 4 min arvioitu lukuaika
...
The genetic detectives discovering who we really are University of Turku 5 min arvioitu lukuaika
...
Deciphering the Gut’s Clues to Our Health University of Turku 5 min arvioitu lukuaika
...
Understanding Users to Optimise 3D Experiences Centrum Wiskunde & Informatica (CWI) 5 min arvioitu lukuaika
...
Harnessing the Rhizosphere to Protect Our Soil Free University of Bozen - Bolzano 5 min arvioitu lukuaika
Lisää artikkeleita